Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CC transcript
Pernix Sleep, Inc. (SOMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/12/2013 8-K Quarterly results
12/21/2012 8-K Other Events
12/11/2012 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger by and among Pernix Therapeutics Holdings, Inc., Pernix Acquisition Corp. I and Somaxon Pharmaceuticals, Inc",
"Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc."
10/31/2012 8-K Quarterly results
Docs: "SOMAXON PHARMACEUTICALS REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS"
10/11/2012 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Somaxon Pharmaceuticals, Inc., effective 5:00 p.m. Pacific Time, October 11, 2012",
"SOMAXON PHARMACEUTICALS APPROVES 1-FOR-8 REVERSE STOCK SPLIT AND DECREASE IN THE NUMBER OF AUTHORIZED SHARES OF ITS COMMON STOCK TO 25,000,000 SHARES"
09/14/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No. 3 to Manufacturing Services Agreement dated September 12, 2012, between Somaxon Pharmaceuticals, Inc. and Patheon Pharmaceuticals Inc"
08/29/2012 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financi...
Docs: "Office Lease Agreement between Somaxon Pharmaceuticals, Inc. and SB Corporate Centre III-IV, LLC",
"Lease Termination Agreement between Somaxon Pharmaceuticals, Inc. and TREA Pacific Plaza, LLC"
08/07/2012 8-K Quarterly results
Docs: "SOMAXON PHARMACEUTICALS REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS"
07/24/2012 8-K Form 8-K - Current report
07/20/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Placement Agent Agreement by and between Somaxon Pharmaceuticals, Inc. and Roth Capital Partners, LLC",
"Form of Warrant",
"Form of Subscription Agreement",
"SOMAXON PHARMACEUTICALS TO RAISE $3.0 MILLION IN REGISTERED DIRECT OFFERING"
06/14/2012 8-K Other Events
06/04/2012 8-K Submission of Matters to a Vote of Security Holders
05/17/2012 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "LICENSE AGREEMENT DATED AS OF APRIL 26, 2012 BY AND BETWEEN SOMAXON PHARMACEUTICALS, INC. AND CJ CHEILJEDANG CORPORATION LICENSE AGREEMENT THIS LICENSE AGREEMENT is made as of April 26, 2012 , by and between Somaxon Pharmaceuticals, Inc., a Delaware corporation, having a place of business at 10935 Vista Sorrento Parkway, Suite 250, San Diego, California 92130, USA , and CJ CheilJedang Corporation, a corporation duly incorporated under the laws of the Republic of Korea with its registered address at CJ Cheiljedang Center, 330, Dongho-ro, Jung-gu, Seoul, 100-400, Korea . Somaxon and Licensee may hereinafter be referred to individually as a “Party” or collectively as the “Parties.” WHEREAS, Licensee desires to license from Somaxon and Somaxon desires to license to Licensee, on an exclusive ba..."
05/02/2012 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "LICENSE AGREEMENT DATED AS OF APRIL 26, 2012 BY AND BETWEEN SOMAXON PHARMACEUTICALS, INC. AND CJ CHEILJEDANG CORPORATION LICENSE AGREEMENT THIS LICENSE AGREEMENT is made as of April 26, 2012 , by and between Somaxon Pharmaceuticals, Inc., a Delaware corporation, having a place of business at 10935 Vista Sorrento Parkway, Suite 250, San Diego, California 92130, USA , and CJ CheilJedang Corporation, a corporation duly incorporated under the laws of the Republic of Korea with its registered address at CJ Cheiljedang Center, 330, Dongho-ro, Jung-gu, Seoul, 100-400, Korea . Somaxon and Licensee may hereinafter be referred to individually as a “Party” or collectively as the “Parties.” WHEREAS, Licensee desires to license from Somaxon and Somaxon desires to license to Licensee, on an exclusive ba...",
"SUPPLY AGREEMENT THIS SUPPLY AGREEMENT made as of April 26, 2012 , by and between Somaxon Pharmaceuticals, Inc., a Delaware corporation, having a place of business at 10935 Vista Sorrento Parkway, Suite 250, San Diego, California 92130, USA, , and CJ CheilJedang Corporation, a corporation duly incorporated under the laws of the Republic of Korea with its registered address at CJ Cheiljedang Center, 330, Dongho-ro, Jung-gu, Seoul, 100-400, Korea . Somaxon and Licensee may hereinafter be referred to individually as a “Party” or collectively as the “Parties.” WHEREAS, Somaxon and Licensee have entered into a License Agreement effective as of the Effective Date , under which Somaxon grants Licensee an exclusive right to Commercialize the Licensed Product in the Field in the Territory . WHEREAS...",
"SOMAXON AND CJ CHEILJEDANG ANNOUNCE SILENOR ® COLLABORATION IN SOUTH KOREA"
04/02/2012 8-K Form 8-K - Current report
03/23/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/08/2012 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "SOMAXON REPORTS FINANCIAL RESULTS FOR FULL YEAR AND FOURTH QUARTER ENDED DECEMBER 31, 2011"
02/27/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Somaxon Pharmaceuticals, Inc. 2012 Incentive Plan"
12/19/2011 8-K Termination of a Material Definitive Agreement, Cost Associated with Exit or Disposal Activities, Notice of Delisting or Fail...
11/25/2011 8-K Form 8-K - Current report
11/03/2011 8-K Form 8-K - Current report
10/11/2011 8-K Regulation FD Disclosure
10/03/2011 8-K Termination of a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointmen...
Docs: "Letter Agreement dated September 30, 2011, between Somaxon Pharmaceuticals, Inc. and The Procter & Gamble Distributing Company LLC",
"Employment Agreement dated September 30, 2011, between Somaxon Pharmaceuticals, Inc. and Michael D. Allen"
08/02/2011 8-K Form 8-K - Current report
06/28/2011 8-K Form 8-K - Current report
06/23/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Somaxon Clinical Data Poster Presentation —"
06/03/2011 8-K Submission of Matters to a Vote of Security Holders
05/27/2011 8-K Other Events
05/25/2011 8-K Form 8-K - Current report
05/24/2011 8-K Investor presentation
Docs: "Company Update Slides"
05/17/2011 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Somaxon Clinical Data Poster Presentations —"
05/12/2011 8-K Other Events
05/10/2011 8-K Other Events
05/03/2011 8-K Quarterly results
Docs: "SOMAXON PHARMACEUTICALS REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy